Best Startup
At Best Startup US we track over 1,000,000 US startups and over 3 million people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top United States based CFO’ operating in the Health Care space. If you think a CFO’ is missing from this list, feel free to contact our editor on editor@beststartup.us.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Erica Moore
CFO of Goop
CFO at goop.com
Follow Erica Moore:
About Goop: Goop is a lifestyle brand providing digital content and commerce.
Matthew De Dominicis
Partner & Chief Financial Officer of Norwest Venture Partners
Matt has more than 16 years of experience in financial management. As Norwest’s Chief Financial Officer, he oversees the firm’s financial operations. Before joining Norwest, Matt was the Chief Financial Officer at Watershed Asset Management, an SEC-registered investment adviser. At Watershed, Matt was responsible for the diverse business operations of the firm, managing over $1 billion across multiple hedge funds. Prior to that, he was fund controller at Highland Capital Partners, where he was part of a team responsible for the finance function for multiple venture capital and private equity funds. Matt previously held positions at Sowood Capital Management, Liberty Mutual Group, and Ernst & Young. Matt holds a BBA with a major in accounting from the Mendoza College of Business Administration at the University of Notre Dame, and an MBA from the University of Massachusetts, Boston. Matt is a certified public accountant.
Follow Matthew De Dominicis:
About Norwest Venture Partners: Norwest is a global venture capital and growth equity investment firm that specializes in venture and growth equity companies.
Tim Schaller
Chief Financial Officer of New Enterprise Associates
Tim Schaller joined NEA in 2008 as Chief Financial Officer and is responsible for finance, investment operations, facilities, and information technology. Prior to joining NEA, Tim was Chief Financial Officer at Algenol Biofuels Inc., a Florida-based alternative energy company. He began his career at PricewaterhouseCoopers (C&L), where he was a Manager specializing in financial services. Tim earned his bachelor’s degree in accounting from Loyola College of Maryland and his master’s degree concentrating in financial management from Johns Hopkins University.
Follow Tim Schaller:
About New Enterprise Associates: New Enterprise Associates is a global venture capital firm investing in technology and healthcare.
Christine A. Tsingos
EVP & CFO of Bio-Rad Laboratories
Ms. Christine A. Tsingos is Chief Financial Officer, Executive Vice President of Bio Rad Laboratories Inc. Previously, she was the Chief Operating Officer and Chief Financial Officer at Attest Systems, Inc., a provider of information technology asset discovery and management tools, from August 2002 to November 2002. Prior to that, Ms. Tsingos was a consultant to Attest Systems, Inc. from October 2000 to July 2002. She was the Chief Financial Officer at Tavolo, Inc., an online retailer of gourmet cookware and food, from November 1999 to September 2000, and she was Treasurer, and later Vice President and Treasurer, of Autodesk, Inc., a developer of design software, from May 1990 to November 1999.
Follow Christine A. Tsingos:
About Bio-Rad Laboratories: Bio-Rad Laboratories has played a leading role in the advancement of scientific discovery for over 50 years by providing a broad range of
Jason Searfoss
Chief Financial Officer & Chief Investment Officer of Boomtown Accelerators
Jason Searfoss is the Chief Financial Officer at Boomtown Accelerator and Altvia Solutions, LLC. In this role, he manages investor relations and financial strategy for the firm. He also leads the finance and fundraising curriculum for the teams that join the accelerator. Before joining Boomtown, Jason Searfoss was the Chief Financial Officer at Longford Capital. He has also worked at The Royal Bank of Scotland Group, GE Capital, AEGON, Samsung and JPMorgan Chase. Jason Searfoss has extensive experience in private equity and corporate finance. He holds an MBA in Finance and Accounting from The University of Chicago Booth School of Business in 1998 and B.A. in Economics and English, Summa Cum Laude from Kenyon College in 1994.
Follow Jason Searfoss:
About Boomtown Accelerators, Numeria Ventures: Boomtown’s bespoke accelerator programs help startups turn ideas into profitable, scalable businesses.
Denise Castillo Rhodes
Executive Vice-President & Chief Financial Officer of Texas Medical Center
Denise Castillo-Rhodes is executive vice president and chief financial officer of Texas Medical Center, where she oversees accounting, finance, billing and collections, and tax compliance. Outside of her work at Texas Medical Center, Castillo-Rhodes serves on several advisory boards, including Post Oak Montessori School, The Audit and Finance Committee of Medical Bridges, Houston Livestock Show and Rodeo Ticket Services, Greater Houston Partnership’s Executive Women’s Partnership, and Greater Houston Women’s Chamber of Commerce. Castillo-Rhodes holds a Bachelor of Business Administration from the University of Texas at El Paso and a Master of Business Administration from the University of St. Thomas. She is a certified public accountant and is a member of the Texas Society of Certified Public Accountants and American Institute of Certified Public Accountants.
Follow Denise Castillo Rhodes:
About Texas Medical Center: Texas Medical Center (TMC) is a life sciences medical complex focused on patient care, research, education, and prevention.
Raydodd Hester
CFO of Greyfinch
Raydodd Hester is the Credit Analyst at Simmons Bank.
Follow Raydodd Hester:
About Greyfinch, Simmons Bank: Greyfinch is an orthodontic practice management software.
Thomas Antonio
Vice President of Financial & CFO of Drive Medical
Thomas Antonio joined the Company in February 2004, and is primarily responsible for financial reporting. From 1986 through 1997, Thomas Antonio served as the Assistant Vice President and Controller of Charan Industries, a privately-held company which owned and operated bowling centers throughout the United States. From 1997 through February 2004, Thomas served as the Chief Financial Officer of several privately-held companies located in the metropolitan New York area.
Follow Thomas Antonio:
About Drive Medical: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
Cory Roberts
Chief Financial Officer of UnitedHealth Group
Cory serves as a Chief Financial Officer and Group President. Prior to SCA, Cory led the development of an analytical systems platform for a private equity portfolio company and worked in the M&A division of a southeastern investment banking group. Cory earned a Bachelor of Science from The University of Alabama.
Follow Cory Roberts:
About Triple Aim Partners, UnitedHealth Group: UnitedHealth Group is a healthcare company that offers insurance products and services for everyone.
Sam Singer
CFO of Bio-Reference Laboratories
Follow Sam Singer:
About Bio-Reference Laboratories: BioReference is the third largest full service clinical diagnostic laboratory in the U.S. providing testing .
David Tamburri
Managing Partner & CFO of Health Enterprise Partners
Follow David Tamburri:
About Columbia University in the City of New York, Health Enterprise Partners: Health Enterprise Partners is a private equity firm that provides its services for healthcare services and information technology companies.
Sailesh R. Saxena
CFO of ReliantHeart
Mr. Saxena is the Chief Financial Officer and Co-Founder of ReliantHeart. He played a critical role in the acquisition of the HeartAssist5 technology. He has more than twenty-five years of leadership and consulting experience in financial services, supply chain management, information technology, research and development, and operations. He has worked with numerous private equity fund companies providing financial consulting and analysis on transactions to raise capital for acquisition or investment projects. He has an MBA from SMU Cox School of Business and Electrical engineering degree from Birla Institute of Technology and Science, Pilani (BITS), India.
Follow Sailesh R. Saxena:
About ReliantHeart: ReliantHeart, Inc. is a leading innovator in mechanical circulatory support therapies for advanced stage heart failure.
Leon Rodriguez
Co-founder & CFO of NecesitoDoc
Co-founder & CFO of NecesitoDoc, prior experience in private equity at BK Partners and Mira Companies, Berkeley-Haas MBA
Follow Leon Rodriguez:
About NecesitoDoc: NecesitoDoc is a telehealth platform that delivers on-demand healthcare via video consultations.
Michael Van Atter
Chief Financial Officer of Marathon Health
Michael Van Atter is the Chief Financial Officer at Marathon Health.
Follow Michael Van Atter:
About Marathon Health: Marathon Health offers a proven solution for helping employers reduce the total cost of healthcare
Joe Selsavage
CFO of Lemonaid Health
Follow Joe Selsavage:
About Lemonaid Health, Metromile: Lemonaid Health is a telemedicine platform that uses technology to change the way people interact with health care.
Chuck Carelli
CFO of Flagship Pioneering
Chuck Carelli, CPA, joined Flagship Ventures in 2009 with 16 years of experience in financial accounting, reporting and management. After obtaining his CPA license while working in the Boston office of Deloitte & Touche, Chuck spent 13 years in various senior financial accounting and management roles at three Massachusetts-based publicly traded biotech companies. From 2004 until joining Flagship, he served in various senior financial roles with EXACT Sciences, most recently as Chief Financial Officer. Previously he was with Alkermes, Inc. serving first as Controller then as Director of Finance. He also served as Accounting Manager and then Director of Accounting at Creative BioMolecules. As CFO, Chuck is responsible for all of Flagship Ventures’ financial and tax reporting, cash flow management, fund audits, and financial administration, as well as the financial operations of Flagship’s VentureLabsTM unit. Chuck holds a BA in Accounting from Assumption College.
Follow Chuck Carelli:
About Flagship Pioneering: Flagship Pioneering is a venture capital firm that invests in life sciences and healthcare companies.
Sravan K. Emany
SVP & Chief Financial Officer of Ironwood Pharmaceuticals
Sravan K. Emany is Chief Financial Officer at Ironwood. Before joining the company in 2021, Mr. Emany served as the Corporate Vice President, Commercial Excellence and Chief Strategy Officer at Integra Lifesciences Holdings Corporation, where he was responsible for the Company’s commercial support functions and led the development of their corporate strategy. Prior to Integra, Mr. Emany was at Bank of America for ten years and held roles of increasing responsibility within the Mergers & Acquisitions (M&A) business, ultimately serving as a Managing Director of the M&A group. Mr. Emany began his career working at several well-respected banking institutions including Morgan Stanley and Goldman Sachs. Mr. Emany has a B.A. in international relations and an M.A. in international relations and international economics, both from Johns Hopkins University.
Follow Sravan K. Emany:
About Ironwood Pharmaceuticals: Ironwood Pharmaceuticals is an entrepreneurial pharmaceutical company, develops drugs for gastrointestinal and cardiovascular diseases.
Gene Castagnini
COO, CFO, CAO & Co-founder of Biocare Medical
Gene J. Castagnini, MS, MBA, co-founded Biocare Medical LLC in 1997 and serves as its Co-Owner and Chief Financial Officer. Gene Castagnini serves as the Chief Operating Officer and Executive Vice President of Biocare Medical, LLC Gene Castagnini served as the Chief Administrative Officer and Chief Financial Officer of BioGenex Laboratories. Inc., for 10 years. Gene Castagnini’s experience includes 15 years as a Director and Officer of Medi-Physics Inc., formerly a Hoffmann-La Roche Inc. subsidiary. Gene Castagnini has a BS in accounting and an MBA in Human Resource Management from the California State University school systems.
Follow Gene Castagnini:
About Biocare Medical: Biocare Medical is a provider of immunohistochemistry instrumentation.
Sotirios Zaharis
Group Chief Financial Officer of Constellation Healthcare Technologies
Sam Zaharis is a qualified Chartered Accountant with over 25 years corporate experience. He most recently served as Chief Financial Officer for Yarra Valley Farms, a wholesale supplier of fruit and vegetables servicing the commercial and hospitality industries in Australia. He has also held roles at Ernst & Young, Ferrier Hodgson and Kroll Inc., and previously worked with Paul Parmar to set up and establish Pegasus Elite Aviation. He has extensive experience in M&A and integration, as well as day to day operational experience, corporate governance in addition to investor and lender reporting.
Follow Sotirios Zaharis:
About Constellation Healthcare Technologies: Constellation Healthcare Technologies provides a holistic, integrated suite of practice management support services to hospitals.
Gerard van Hamel Platerink
Chief Financial Officer of Genalyte
Board Member at HealthMine, MedAvail Technologies & Genalyte.
Follow Gerard van Hamel Platerink:
About Accuitive Medical Ventures, Genalyte, Redmile Group: Genalyte is a life sciences company developing and commercializing innovative next-generation multiplexing technology.
Alan Nielsen
Chief Financial Officer of Walgreens
Alan Nielsen is chief financial officer for Walgreen Co. based in Deerfield, Illinois. Nielsen has been with Walgreens since 1987. Prior to being promoted to his current role, Nielsen was group vice president of International Finance. Before that, he served as director of results and director of decision support systems. Previously, he held several finance and accounting roles in the company. Nielsen received a bachelor of science degree in accounting from Eastern Illinois University in 1987 and earned a CPA designation in 1990.
Follow Alan Nielsen:
About Walgreens: Walgreens provides multi-channel access to consumer goods and cost-effective pharmacy, health, and wellness services.
Leonard Bruce Jolliff
Chief Financial Officer of Vivos Inc
Leonard Bruce Jolliff, joined Advanced Medical Isotope Corporation as Chief Financial Officer in 2006. For nine years prior to joining the Company, Mr. Jolliff was a sole practitioner in the role of CFO for Hire and as a Forensic Accountant, working with companies ranging from Fortune 500 to small family operations. Mr. Jolliff is a CPA and a member of the Washington Society of CPAs. He is also a Certified Fraud Examiner and a member of the Association of Certified Fraud Examiners. Mr. Jolliff has held CFO and Controller positions in an array of industries and has worked as a CPA in public practice. Currently all of Mr. Jolliff’s energy is focused on supporting AMI’s isotope production and securing new investments which will enable the growing company to meet it’s goals.
Follow Leonard Bruce Jolliff:
About Vivos Inc: Vivos Inc develops manufacturing equipments for the production of medical isotopes used in diagnosis and treatment of diseases.
Jeanne Henry
CFO of Excel Venture Management
Jeanne joined the Excel team in 2009 and brings more than 18 years of venture capital financial management and reporting experience to the team. Previously, Jeanne was CFO and most recently COO with Atlas Venture, an international venture firm. Earlier she was an Audit Manager with Coopers & Lybrand (now PricewaterhouseCoopers). Jeanne holds a B.A. from the University of New Hampshire, an MBA from the University of Illinois, Chicago and is a Certified Public Accountant. She is a member of the AICPA, the M.A. Society of CPA’s, and a former Board member of the Private Equity CFO Association.
Follow Jeanne Henry:
About Excel Venture Management: Excel Venture Management builds companies that apply transformative life science technologies to solve problems in healthcare and beyond.
William Guest
Chief Financial Officer of Angle Health
William Guest is the Chief Financial Officer at Angle Health.
Follow William Guest:
About Angle Health: Angle Health delivers the modern health insurance experience expected by today’s employees.
Neil Edwards
Chief Financial Officer of Vesselon
Neil Edwards is the CEO of Cellufun. Edwards served as the founding CEO of dotMobi, a mobile web services company, where he grew the company from a start-up to a multi-million dollar organization. At dotMobi he built a global customer base with multiple channel platforms and content partners that generated significant recurring revenue streams. Additionally,Mr. Edwards was instrumental in building a consortium of leading mobile brands including Nokia, Vodafone, Google, Telefonica, Telecom Italia, T-Mobile, Orascom, Microsoft, Visa and many others. Prior to dotMobi, he was instrumental in the growth of VeriSign and infoUSA,having served in senior leadership positions within both organizations.
Follow Neil Edwards:
About Forbes, Vesselon: Vesselon is a medical device company developing novel therapeutic Immuno-Oncology complexes.
Karick Stober
Executive Vice President & Chief Financial Officer of Post Acute Medical
Karick serves as the Vice President of Mergers and Acquisitions and is responsible for analyzing potential development and acquisition candidates as well as providing financial forecasts and analysis. With over thirteen years of experience in the healthcare field, where he was a former associate at Pricewaterhouse Coopers, LLP, Karick created financial models and provided economic analysis for healthcare clients. Most recently, Karick served as a Manager of Financial Planning at Select Medical Corporation, where he was responsible for treasury management, financial forecasting and analysis.
Follow Karick Stober:
About Post Acute Medical: Post Acute Medical is a specialty healthcare company focused on providing high quality, post-acute care.
Karick Stober
Executive Vice President & Chief Financial Officer of Post Acute Medical
Karick serves as the Vice President of Mergers and Acquisitions and is responsible for analyzing potential development and acquisition candidates as well as providing financial forecasts and analysis. With over thirteen years of experience in the healthcare field, where he was a former associate at Pricewaterhouse Coopers, LLP, Karick created financial models and provided economic analysis for healthcare clients. Most recently, Karick served as a Manager of Financial Planning at Select Medical Corporation, where he was responsible for treasury management, financial forecasting and analysis.
Follow Karick Stober:
About Post Acute Medical: Post Acute Medical is a specialty healthcare company focused on providing high quality, post-acute care.
Kevin Gillis
CFO / Partner of Third Rock Ventures
Kevin Gillis joined Third Rock Ventures in 2008 and oversees the operational, financial and administrative aspects of the firm. He also directs and oversees the initial operational activities for our portfolio companies. Kevin has approximately 20 years of financial experience, successfully designing, overseeing and managing the financial operations for both newly emerging and established biotech companies. Prior to joining Third Rock Ventures, Kevin was Vice President of Finance at Coley Pharmaceutical Group, supporting the company’s successful initial public offering in 2005 and overseeing the finances related to the company’s acquisition by Pfizer in 2008. Prior to Coley, Kevin served in a number of senior finance roles at Millennium Pharmaceuticals and The Coca-Cola Company. Kevin holds an MBA from Bentley University and a BA from Brandeis University.
Follow Kevin Gillis:
About Third Rock Ventures: Third Rock Ventures invests in transformational life science companies that show high growth potential
Jason Klarreich
Managing Director, CFO, COO, & CCO of JW Asset Management
Jason Klarreich is the managing director, CFO, COO, and CCO at JW Asset Management. Before joining JWAM, Jason was a director and trader at Heartland Securities. He previously worked in fixed income sales at Morgan Stanley and at Smith Barney as a financial analyst in the asset management division. Jason serves on the board at Arbor Pharmaceuticals. He graduated from Emory University with a bachelor’s degree in finance.
Follow Jason Klarreich:
About JW Asset Management: JW Asset Management is a New York-based investment firm that primarily invests within the healthcare sector.
Gina Hicks
Chief Financial Officer of Omega Healthcare
As CFO of the organization, Gina is responsible for all the finance operations in US, India and Philippines. Prior to joining Omega she served as the Chief Financial Officer of Vapor Corp (VPCO) (OTCPink: VPCO), that operated a chain of retail stores, and an organic grocery store, through its wholly-owned subsidiary Healthy Choice Markets, Inc, during 2016 and 2015. Ms. Hicks served as the interim Chief Financial Officer of Health Revenue Assurance Holdings, Inc. (HRAH) (OTCPink: HRAA), a medical coding company, during 2014. From 2011 until 2013, Ms. Hicks served as the Vice President of Finance of MeetMe, Inc. (NASDAQ: MEET), a social network. Prior to that, Ms. Hicks was an independent consultant providing accounting and business advisory services and was a lead senior manager with PricewaterhouseCoopers assurance practice. Ms. Hicks is a Certified Public Accountant in the State of Florida, a member of the American Institute of Certified Public Accountants, and is a Chartered Global Management Accountant.
Follow Gina Hicks:
About Omega Healthcare: Omega Healthcare, a front-runner in the healthcare service space in India.
Mimi Kwan
Chief Financial Officer of Spire Health
Mimi Kwan is the Chief Financial Officer of Spire Health.
Follow Mimi Kwan:
About Spire Health: Spire Health is the market leader in continuous respiration sensing and high-adherence, patient-friendly ambulatory monitoring.
Andrew Miller
CFO of Sopris Capital Associates
Follow Andrew Miller:
About Sopris Capital Associates: Sopris Capital Associates, a U.S.-based investment firm, offers growth capital to healthcare and technology-enabled B2B service businesses.
James Engelhart
Chief Financial Officer of Biohaven Pharmaceutical
Follow James Engelhart:
About Biohaven Pharmaceutical: Biohaven is engaged in the identification and development of clinical stage neuroscience compounds targeting the glutamatergic system.
Shaun Holt
CFO of Berkeley Lights
Shaun joined Berkeley Lights in November 2015 and was appointed Chief Financial Officer in March 2016. Prior to becoming CFO, Shaun was Vice President of Finance. Prior to joining Berkeley Lights, Shaun spent 7 ½ years at Illumina, Inc. heading up various aspects of their Finance organization. His roles included Sr. Director, Global Head of R&D and Business Unit Finance, EMEA Head of Finance, Accounting and Facilities, and Commercial FP&A. He earned a B.S. in Finance from California State University, Stanislaus.
Follow Shaun Holt:
About Berkeley Lights: Berkeley Lights is a provider of research and development services using micro-droplet technology that change the biological processes.
Thomas Altier
CFO of Phreesia
Tom brings over 30 years of financial management experience to the chief financial officer role, including a “Big Four” career foundation and experience with several venture-backed, emerging-growth and SaaS businesses. As CFO of Phreesia, Tom is responsible for budgeting, forecasting, monthly reporting, financial analysis and internal controls. Prior to joining Phreesia, Tom was CFO at Perceptive Pixel, a developer of high-end, multi-touch display screens and related software, which was acquired by Microsoft in 2012. Tom is a CPA, and holds a BA and MBA from Columbia University.
Follow Thomas Altier:
About Phreesia: Phreesia automates the patient check-in process by collecting personal health information on the PhreesiaPad.
Robert Bermon
Chief Financial Officer of Invo HealthCare Holdings
Robert Bermon, CPA brings more than 20 years of senior financial management experience to the Invo Family of Companies and currently serves as the organizations chief Financial Officer. As CFO, Bob oversees the shared services support team which includes accounting, finance and human resources. Prior to Bob joining the team in 2016, he was the Executive Vice President and Chief Financial Officer at Solomon Edwards. Through streamlined business operations, financial controls and processes that drove growth, efficiency and bottom-line profit, Bob was instrumental in building the infrastructure that promoted the company’s growth. Bob’s career started with accounting firm Grant Thornton. Bob holds a Bachelor of Arts in Accounting from Temple University and is a Certified Pubic Account (CPA).
Follow Robert Bermon:
About Invo HealthCare Holdings: Founded in 1993 by Patrick McClain, an Occupational Therapist, and Mary McClain, an Educator.
Ommer Chohan
Chief Financial Officer of Atlas Venture
Ommer Chohan joined Atlas in 2015 and servers as the firm’s Chief Financial Officer. He oversees the firm’s financial, legal, and operations functions. Prior to joining Atlas, Ommer was CFO/COO at Summerhill Venture Partners. Ommer joined Summerhill in 2006 and was part of the original team that spun out the firm from Bell Canada. At Summerhill Ommer was responsible for the finance, IT, and administrative functions in addition to providing financial and legal support to the investment team. Prior to Summerhill, Ommer was the VP-Finance at First Asset Management Inc. (acquired by Affiliated Managers Group), a holding company with equity interests in several leading Canadian asset management firms. Ommer received his BA-Honours, Specialist in Management from the University of Toronto, his MBA from the Johnson School at Cornell University, and earned his CPA (Ontario) while at PricewaterhouseCoopers.
Follow Ommer Chohan:
About Atlas Venture: Atlas Venture creates and invests in biotech startup companies with seed and early stage venture investments.
Joe Franzi
Partner Emeritus, CFO of Seven Peaks Ventures
Joe has been SPV’s CFO since its beginning days and recently retired this Spring. Believing in the foundational importance of supporting companies growing to scale with the right amount of information, operational support and business savvy, Joe brings a wealth of clear business acumen and focused decision making to support our portfolio companies.
Follow Joe Franzi:
About Seven Peaks Ventures: Seven Peaks Ventures is an early-stage venture capital fund focused on funding highly scalable software businesses.
Hiep Pham
CFO of Clever Care Health Plan Inc.
Hiep Pham is the CFO at Clever Care Health Plan.
Follow Hiep Pham:
About Clever Care Health Plan Inc.: Clever Care Health Plan is a healthcare company that offers medicare advantage health plans to its members.
Brian Yoor
Senior Vice President Finance & Chief Financial Officer of Abbott
Brian Yoor is Senior Vice President Finance and Chief Financial Officer. He was appointed to his current position in June 2015. He previously served as Vice President, Investor Relations. Brian joined Abbott in August 1997, and held various financial management positions of increasing responsibility, including Controller positions in the pharmaceutical, nutrition, and diagnostic businesses, before being asked to lead Abbott’s Investor Relations effort in January 2013. Prior to joining Abbott, Brian was a certified public accountant with Arthur Andersen and held financial positions in the consumer industry with the Scotts Company and Newell Rubbermaid. “In Abbott Finance, we are the stewards that enable financial reliability and growth for Abbott, “ Says Brian. “ A strong, growing company is better able to help people around the world live their healthiest lives.” Brian serves on the board of the Clara Abbott Foundation. He is a member of NIRI, the National Investor Relations Institute. He earned his bachelor’s degree in accounting at the University of Toledo in Ohio.
Follow Brian Yoor:
About Abbott: Abbott is engaged in pharmaceuticals and manufacturing healthcare products.
Georgia Erbez
Chief Financial Officer of Harpoon Therapeutics
Georgia Erbez currently works as the Chief Financial Officer for Harpoon Therapeutics. She previously worked at Artelo Biosciences, Inc. as the Member Board Of Directors.
Follow Georgia Erbez:
About Harpoon Therapeutics: Harpoon Therapeutics is a clinical-stage immunotherapy company developing novel T cell engagers (TriTACs) for the treatment of cancer.
Brett Kaplan
Chief Financial Officer of Prevail Therapeutics
Brett Kaplan is our Chief Financial Officer. Prior to Prevail, he was Managing Director at Evercore, where he spent eight years concentrating on biopharma M&A and equity financings. Prior to Evercore, Brett was an Equity Research Analyst at Cowen, where he covered large cap pharmaceuticals. Earlier in his career, he held senior positions at Cubist and Lilly focused on corporate and business development. Brett holds an MBBCh and an MBA from the University of Witwatersrand in South Africa.
Follow Brett Kaplan:
About Prevail Therapeutics: Prevail Therapeutics is a biotechnology company focused on developing novel gene therapies for patients with Parkinson’s disease.
George Radman
Co-Founder & CFO of Vivoo
Follow George Radman:
About Vivoo: Vivoo is a wellness assistant that provides custom nutrition advice to the users based on their urine sample analysis.
Adam Cutler
Chief Financial Officer of Molecular Templates
Adam Cutler has served as Molecular Templates’ Chief Financial Officer since November 2017.Prior to joining Molecular Templates, he was Senior Vice President of Corporate Affairs at Arbutus Biopharma from 2015-2017, where his responsibilities included investor relations, business development, and corporate finance. From 2012-2015, he was a Managing Director for The Trout Group and Trout Capital, where he executed financings and advised life science companies on investor relations, capital raising, and business development. From 2000-2011, he was a biotechnology equity research analyst at Credit Suisse, Canaccord Genuity, JMP Securities, and Bank of America Merrill Lynch. He also worked in healthcare consulting at The Frankel Group and Ernst & Young. He currently serves on the Board of Directors for Inmed Pharmaceuticals and Navidea Biopharmaceuticals. He received his B.A. in Economics from Brandeis University.
Follow Adam Cutler:
About Molecular Templates: Molecular Templates develops novel therapeutic compounds for cancer.
David Sachs
Chief Financial Officer of ImmunityBio
In July 2019, ImmunityBio hired David Sachs as its Chief Financial Officer. As a finance, private equity, venture capital, and investment banking executive, he has over two decades of operational, development, and investing expertise. Sachs was formerly the CFO of various NantWorks companies, including NantHealth and Integrity Healthcare. He was also a principal and executive of NantCapital, where he sat on the investment committee. Sachs formerly worked as an investment banker for Bank of America Merrill Lynch and in senior operational roles at Abraxis BioScience and Celgene. He is now on the boards of Mox Networks, LLC, Packetfabric, Inc., and the Chan Soon-Shiong Medical Center at Windber. Sachs earned his MBA in Finance and Strategy from UCLA Anderson School of Management, as well as his BA in Economics from the University of California, Los Angeles.
Follow David Sachs:
About ImmunityBio, NantHealth: ImmunityBio is an offshoot of Soon-Shiong’s NantWorks conglomerate, developing molecular-level cell-based treatments for diseases.
Steven Schwen
Chief Financial Officer of Vensana Capital
Steve Schwen joined Split Rock Partners at the firm’s inception as Chief Financial Officer. He currently oversees the finance, accounting, operations and human resources activities of the firm. Prior to joining Split Rock Partners, Steve was Chief Financial Officer of St. Paul Venture Capital, which he joined in 1998. Before joining St. Paul Venture Capital, he spent four years in the audit practice of KPMG LLP. He provided audit and consulting services to both public and private financial services companies including investment companies, mutual funds, investment managers and investment banks. Steve became a licensed CPA in the state of Minnesota after earning a BA degree in business administration-accounting at the University of St. Thomas. He is a member of the American Institute of Certified Public Accountants and the Minnesota Society of Certified Public Accountants.
Follow Steven Schwen:
About Split Rock Partners, St. Paul Venture Capital, Vensana Capital: Vensana Capital is a venture capital investment firm that focuses on healthcare with breakthrough innovations in medical technology.
Bryan Perler
SVP & CFO of Sapphire Digital
Bryan has deep experience leading technology companies through fast-paced and high growth environments. As Chief Financial & Administrative Officer, Bryan is responsible for leading and guiding the organizations’ financial growth and ensuring the integrity of the data across the organization; overseeing finance, data engineering, analytics, quality, IT and facilities. Before Sapphire Digital, Bryan was the CFO and Head of Strategy at Benchmark Solutions where he oversaw all strategic, financial and legal activities for the company. He also worked at Tradeweb Markets in a variety of escalating accounting, finance and business development roles, most recently as Director of U.S. Strategy and Business Development. Bryan graduated from Lehigh University with a BS in Accounting.
Follow Bryan Perler:
About Sapphire Digital, Sapphire Digital: Sapphire Digital is a full omnichannel digital engagement and shopping platform for consumers, employers.
Thomas A. Lettero
CFO of Exact Imaging
CEO at NexGen Technology.
Follow Thomas A. Lettero:
About Exact Imaging, NexGen Technology: Exact Imaging is the developer of the ExactVu™ system, the first micro-ultrasound operating at 29 MHz that provides unmatched resolution.
Howard Horn
CFO of Vir Biotechnology
Howard Horn is the Chief Financial Officer of VIR. Previously, he led the Financial Planning and Corporate Finance functions at Biogen. Prior to joining Biogen, he held positions of increasing responsibility and was focused on the life sciences as a consultant with McKinsey & Company and as an equity research analyst at UBS. Howard holds an M.B.A from the Wharton School of the University of Pennsylvania and a B.A in Economics from Princeton University.
Follow Howard Horn:
About Vir Biotechnology: Vir Biotechnology is a clinical-stage immunology company developing therapeutic products to treat and prevent serious infectious diseases.
Robin L. Praeger
CFO, Managing Director of Versant Ventures
Robin and his team have primary responsibility for Versant’s financial, legal, Investor Relations and administrative functions. Robin brings over twenty years of professional services and financial experience to Versant. Prior to joining Versant in 2000, Robin was a tax partner with Arthur Andersen, and has extensive experience in partnership formation and structuring issues. At Anderson his client base included large real estate partnerships and corporations. Robin received a Bachelor’s degree in Political Economics of Industrial Societies from the University of California, Berkeley, and a Master’s degree in Taxation from Golden Gate University. He is a Certified Public Accountant and a member of the AICPA and the California State Board of Accountancy. Robin currently sits on the Board of the West Coast Chapter of the Private Equity Chief Financial Officer Association and is a member of the NVCA CFO Task Force.
Follow Robin L. Praeger:
About Versant Ventures: Versant Ventures caters to the healthcare sector with early and later stage venture, private equity, and debt financing investments.
Spencer Lee
CFO of Hims & Hers
Follow Spencer Lee:
About Hims & Hers: Hims is a wellness brand that helps men and women get access to products for skin care, hair loss, and sexual health.
Brent Faduski
CFO of SV Health Investors
Brent Faduski joined SVLS in October 2008 as Controller and focuses on finance and accounting matters for the firm. Prior Experience: Prior to joining SVLS, Brent was the Controller at CMGI @Ventures, the venture capital affiliate of CMGI, where he was responsible for the accounting and finance aspects of the firm. Prior to joining CMGI @Ventures, Brent was a Senior Associate in the Technology Group at PricewaterhouseCoopers where his clients included early stage venture backed companies as well as venture capital funds.
Follow Brent Faduski:
About SV Health Investors: SV Health Investors is a Boston-based venture capital firm focused on investments in biotechnology and healthcare industry.
Brent Faduski
CFO of SV Health Investors
Brent Faduski joined SVLS in October 2008 as Controller and focuses on finance and accounting matters for the firm. Prior Experience: Prior to joining SVLS, Brent was the Controller at CMGI @Ventures, the venture capital affiliate of CMGI, where he was responsible for the accounting and finance aspects of the firm. Prior to joining CMGI @Ventures, Brent was a Senior Associate in the Technology Group at PricewaterhouseCoopers where his clients included early stage venture backed companies as well as venture capital funds.
Follow Brent Faduski:
About SV Health Investors: SV Health Investors is a Boston-based venture capital firm focused on investments in biotechnology and healthcare industry.
Terry Brady
Chief Financial Officer of Farcast
With over 20 years of experience in finance and accounting, Terry joined Farcast in 2019. As the CFO, he leads HR, Finance, IT, Legal, and Business Analytics. His past experience includes success in public accounting, turnaround management consulting, and most recently as CFO of a large manufacturing company. He holds undergraduate and graduate degrees from the University of Notre Dame as well as an MBA from the Kellogg School of Management at Northwestern University.
Follow Terry Brady:
About Farcast: Farcast develops a diagnostic platform that delivers powerful predictions for personalized cancer treatment selection and drug development.
Marc Naughton
EVP & CFO of Cerner
As executive vice president and chief financial officer, Marc has executive responsibility for Cerner’s financial operations and business model. Playing a key role in Cerner’s rapid rise, Marc ensures the company is growing profitably while maintaining the ability to invest heavily in future growth. Additionally, he carries responsibility for Cerner properties and legal functions, which are both large organizations that facilitate Cerner’s growth. Joining Cerner in 1992 as a finance executive and tax manager, Marc established the company’s internal tax function. He then assumed leadership of Cerner’s mergers, acquisitions and finance activities. He served as the director of finance for two years before being promoted to chief financial officer. Prior to Cerner, Marc had extensive experience in the financial industry, including at Klynveld Peat Marwick Goerdeler (KPMG) and various financial management roles at the Marley Company, a Kansas City, Missouri-based multinational manufacturing company. Marc is a certified public accountant and a member of the Kansas Bar Association. He is a past president of the Kansas City chapter of the Tax Executives Institute and a current member of the University of Kansas Finance Advisory Board. Marc earned a bachelor’s degree in business administration from Southern Methodist University and a juris doctorate from the University of Kansas.
Follow Marc Naughton:
About Cerner: Cerner is a supplier of healthcare information technology solutions, services, devices, and hardware.
Harrison Hellner
Chief Financial Officer of QGenda
As Chief Financial Officer, Hellner is responsible for building all financial operations and maintaining fiscal controls to support the company’s rapid expansion. Additionally, he is responsible for strategic partnerships and M&A. Prior to joining QGenda, Hellner spent the last six years at Raymond James Healthcare Investment Banking Group working with technology businesses to help them with a variety of capital raising activities, including debt and equity financings and M&A. He holds a B.S.
Follow Harrison Hellner:
About QGenda: QGenda is the leading innovator in enterprise healthcare workforce management solutions.
Kathryn E. Falberg
Executive Vice President and Chief Financial Officer of Jazz Pharmaceuticals
Kathryn Falberg was appointed our Executive Vice President and Chief Financial Officer in March 2012. She served as our Senior Vice President and Chief Financial Officer from 2009 to 2012. Her responsibilities include finance, strategy, corporate development and IT. From 1995 through 2001, Kathryn Falberg was with Amgen, Inc., where she served as Senior Vice President Finance, Strategy and Chief Financial Officer, and before that as Vice President, Controller and Chief Accounting Officer, and Vice President, Treasurer. From 2001 through 2008, Kathryn Falberg was President of Canyon Capital & Consulting, a private investment and consulting firm, where she worked with a number of smaller companies while also serving as a corporate director and audit committee chair for several companies. From February to November 2009, she was Chief Financial Officer and Chief Operating Officer at ARCA biopharma, Inc., a biopharmaceutical company. Kathryn Falberg received an M.B.A. and B.A. in Economics from the University of California, Los Angeles and is a Certified Public Accountant (inactive). Kathryn Falberg currently serves on the boards, and is chair of the audit committees, of biopharmaceutical companies Halozyme Therapeutics, Inc. and Medivation, Inc.
Follow Kathryn E. Falberg:
About Jazz Pharmaceuticals: Jazz Pharmaceuticals is a specialty pharmaceutical company that identifies, develops and commercializes innovative treatments.
James Hinrichs
Executive Vice President and Chief Financial Officer of Alere
James (“Jim”) Hinrichs joined Alere in April 2015 as Executive Vice President and Chief Financial Officer, with global responsibility for Finance, Accounting, Procurement, IT and Shared Services. Prior to his appointment as CFO of Alere, Jim Hinrichs was CFO at CareFusion Corp., a global medical technology corporation, since 2010. He held this position through the completion of Becton Dickinson’s acquisition of CareFusion in March 2015. Prior to this role, Hinrichs served as SVP of Global Customer Support and, before that, Corporate Controller of CareFusion. Previously, he was Executive Vice president and Controller of Cardinal Health, CFO of Cardinal Health’s Clinical and Medical Products segment and CFO of Cardinal Health’s Healthcare Supply Chain Services segment.. He joined Cardinal Health in February 2004, following 12 years of finance and marketing roles at Merck & Co. and two years as the CFO of SangStat Medical Corporation.
Follow James Hinrichs:
About Alere: Alere provides diagnostics and health management solutions for infectious, heart and cancer-related diseases and drug addicts.
Tobias Mezger
Co-Founder – COO/CFO of PayZen
I am passionate about solving big problems by making financial services more straightforward and more accessible. I am excited about building a great company.
Follow Tobias Mezger:
About PayZen: PayZen is a health care fintech startup that aims to tackle the growing patient payment responsibility problem.
Ken Myszkowski
Chief Financial Officer of Arrowhead Pharmaceuticals
Follow Ken Myszkowski:
About Arrowhead Pharmaceuticals: Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.
Tony Hughes
Chief Financial Officer of NaviHealth
Tony Hughes serves as naviHealth’s Chief Revenue and Strategy Officer responsible for leading new health plan and health system business opportunities. Prior to joining naviHealth, Tony specialized in managed care mergers and acquisitions. Most recently he served as Director of Corporate Development at WellCare Health Plans and prior to that as Director of Corporate Development and Investor Relations for HealthSpring, Inc.
Follow Tony Hughes:
About NaviHealth: NaviHealth partners with health plans, health systems and post-acute providers to manage the entire continuum of post-acute care.
Michael Coggin
EVP & CFO of LifePoint Health
Michael Coggin serves as Executive Vice President and Chief Financial Officer for LifePoint Health, providing the Company corporate and healthcare finance leadership. Previously, Coggin served as Senior Vice President and Chief Accounting Officer for LifePoint since December 2008. In that role Coggin, was responsible for the Company’s external financial reporting, corporate accounting and consolidation functions, tax functions and the Company’s internal control compliance requirements. Additionally, Coggin has held certain responsibilities associated with the Company’s treasury and finance functions. Prior to joining LifePoint, Coggin was Chief Financial Officer of Specialty Care Services Group. He also served in finance leadership positions for Renal Care Group, Inc. from April 2004 until its acquisition by Fresenius Medical Care AG & Co. KGaA in March 2006. He began his professional career as an auditor with KPMG Peat Marwick.
Follow Michael Coggin:
About LifePoint Health: LifePoint Health is a leading healthcare company dedicated to Making Communities Healthier.
Amrita Bhandari
CFO of Acumen
Acumen’s focus on building a world based on dignity through creative though tangible solutions is why I am so passionate about working here.” Amrita is Acumen’s global CFO, responsible for financial operations across our geographies, strategy, planning and reporting. Prior to Acumen, Amrita was CFO of Katzenbach Partners, a dynamic management consulting firm and was instrumental in the merger integration of Katzenbach with Booz & Co. In addition to her management role, she consulted with clients across a range of industries with a focus on strategy and planning. Since then, she developed her own independent consulting practice with a focus on inspiring organizations in the social sector. Amrita has worked with Acumen in the past as a strategy consultant covering a range of topics such as clarifying Acumen’s business model, developing a multi-year operating plan and evaluating Acumen’s employee compensation plans. Amrita has also worked with Management Leadership for Tomorrow, Edelman and other professional services firms. Amrita received a BA in International Relations from The College of Wooster.
Follow Amrita Bhandari:
About Acumen: Acumen is a non-profit venture fund that uses entrepreneurial approaches to solve the problems of global poverty.
Victor Breed
Chief Financial Officer of Genoa
Victor Breed is Genoa, a QoL Healthcare Company’s Chief Financial Officer. Breed joined Genoa in October 2006. Breed is responsible for accounting functions, treasury management, billing, purchasing, insurance/risk management and banking and investor relationships. He plays a significant role in raising equity financing and negotiating new bank financing. Previously Breed was the EVP of Finance and Operations for a medical device company, ClearMedical, Inc. As the EVP, Breed developed and implemented a new business model and managed all operational and administrative functions including production, engineering, regulatory, finance, accounting, human resources and IT. Prior to ClearMedical, Inc., Breed served as Senior Vice President for Solucient, LLC. While with Solucient, he was the General Manager of the business unit providing performance management solutions for hospitals. In addition, he identified and evaluated potential business partners and M&A candidates and negotiated business relationships, joint ventures and marketing arrangements. Before working for Solucient, LLC, Breed was the COO and CFO for HBS International. As COO/CFO Breed oversaw daily operations and developed strategies for accelerating growth by merger or acquisition. HBS International was one of the Deloitte & Touche Technology Fast 500; a list of the fastest growing technology companies in North America and on the 2000 Healthcare Informatics list of 10 Most Influential Healthcare IT Companies. Breed is a graduate of Lake Superior State University with a Bachelor of Science in Accounting. He is also a member of both the American Institute of Certified Public Accountants and the Washington Society of Certified Public Accountants.
Follow Victor Breed:
About Genoa: Genoa, a QoL Healthcare Company is the pharmacy and telepsychiatry provider serving the behavioral health and addiction treatment.
Gillian Munson
Chief Financial Officer of Iora Health
Follow Gillian Munson:
About Iora Health: Iora Health is a healthcare company that helps patients manage their health and navigate the healthcare system.
Mark Hirschhorn
COO & CFO of Teladoc Health
Follow Mark Hirschhorn:
About Teladoc Health: Teladoc is a global provider of virtual care, transforming the access, cost, and quality dynamics of health care delivery.
Frederick J. Crawford
Executive Vice President; Chief Financial Officer of Aflac
Fred Crawford joined Aflac in June 2015 as executive vice president and chief financial officer of Aflac Incorporated, responsible for overseeing the financial management of company operations. He brings nearly three decades of financial and leadership experience to Aflac. Most recently, he served as executive vice president and chief financial officer of CNO Financial Group since 2012. Prior to that, he spent more than a decade at the Lincoln Financial Group serving in roles of progressive responsibility, including as executive vice president and chief financial officer as well as leading Corporate Development and Investments. Before joining Lincoln Financial Group, he also held leadership positions at Bank One Corporation. Fred received his bachelor of arts degree from Indiana State University and a master of business administration degree from the University of Iowa, where he currently serves as an advisory board member with the Finance Department at its Tippie College of Business.
Follow Frederick J. Crawford:
About Aflac: Aflac is a company that offers individuals and companies supplemental disability insurance.
Rick Kent
CFO of Paramit Corporation
Rick Kent is the Chief Financial Officer at Paramit Corporation.
Follow Rick Kent:
About Paramit Corporation: Paramit designs and manufactures medical devices and life science instruments.
Tom LaRose
CFO of Paramit Corporation
Tom LaRose is CFO at Paramit Corporation.
Follow Tom LaRose:
About Paramit Corporation: Paramit designs and manufactures medical devices and life science instruments.
Denise Ferre
Partner, CFO of Moneta Ventures
Denise Ferre is a partner at Moneta Ventures and its CFO. Prior to joining Moneta Ventures, Denise was the CFO and co-founder at Sparta Consulting, a global IT consulting firm. She spearheaded the financial operations of the $100+ million company with over 1,500 employees. Besides the financial operations, Denise was also responsible for HR, IT and legal departments at Sparta . Before Sparta, Denise was the Business Unit Controller at Rapidgm, a global IT consulting firm, and later assumed the role of U.S. Controller when the firm was acquired by Fujitsu in 2006. Denise has a Bachelor’s Degree in Business Administration and Accounting.
Follow Denise Ferre:
About Moneta Ventures: Moneta Ventures is a venture capital firm that invests in early-stage technology and healthcare businesses.
Niall O’Cathasaigh
CFO of Prealize Health
As CFO, Niall O’Cathasaigh is the senior executive responsible for sound fiscal management of all financial operations and human resource activities, as well as overseeing capital raising efforts and financial reporting for board and other stakeholder communications. Niall has been working as a founder and consultant with startups and growth stage companies in the US, Europe and Africa for over 20 years. He works with Countsy, an innovative professional services firm that specializes in working with venture funded startups to provide end to end strategic and back office services. His experience includes work with over 30 startups in the Bay Area, with a focus on healthcare companies, providing financial transparency and strategic guidance as well as enabling funding rounds and acquisitions. Niall is also a founder and partner of ManoCap, a private equity fund management company that makes equity investments in small to mid-cap enterprises in West Africa. Prior to that he worked at Apple’s European divisions in Ireland and France. Niall is a qualified financial professional (CIMA). He holds a postgraduate degree in business from University College Dublin, and a joint BA in History and Classical Civilization from University College Galway and Universite De Poitiers.
Follow Niall O’Cathasaigh:
About Prealize Health: Prealize Health uses machine learning to transform healthcare from reactive to proactive.
Karen Adams
CFO of Arrivo BioVentures LLC
Karen Adams has a 30 year career as a finance professional working with companies across a broad range of industries with the last 15 years focused on life sciences and technology. After starting her career as an Internal Auditor with International Paper Company, Inc., Karen Adams has held financial leadership positions with companies in software, professional services and biotechnology industries. Most recently, Karen Adams has been part of the management team, in the CFO role, responsible for the creation and sale of two companies (Addrenex Pharmaceuticals to Shionogi Pharma and Neuronex to Acorda Therapeutics) and Aerial BioPharma’s ADX-N05 asset sale to Jazz Pharmaceuticals. While Karen Adams life sciences experience has been primarily focused on early-stage, privately funded companies she was brought on as Assistant Controller at Millennium Pharmaceuticals, Inc. during its merger with COR Therapeutics – among the largest such mergers in the history of the biotech industry at that time. After Millennium Pharmaceuticals, Karen Adams went on to work with several early stage biotechnology ventures including Surface Logix, Inc., Compound Therapeutics, Inc., Galenea Corporation, BG Medicine, Inc., and Micell Technologies, Inc. Karen Adams contribution was concentrated on the creation of dynamic, integrated financial forecasting models as well as the implementation of core business structure. Karen Adams graduated from Boston College earning a BS in Management, majoring in Finance.
Follow Karen Adams:
About Arrivo BioVentures LLC, Emergo Therapeutics, KJA Associates, QuatroBio: Arrivo BioVentures is a pharmaceutical development company which focuses on identifying biologics and molecules to improve patient care.
Karen Adams
CFO of Arrivo BioVentures LLC
Karen Adams has a 30 year career as a finance professional working with companies across a broad range of industries with the last 15 years focused on life sciences and technology. After starting her career as an Internal Auditor with International Paper Company, Inc., Karen Adams has held financial leadership positions with companies in software, professional services and biotechnology industries. Most recently, Karen Adams has been part of the management team, in the CFO role, responsible for the creation and sale of two companies (Addrenex Pharmaceuticals to Shionogi Pharma and Neuronex to Acorda Therapeutics) and Aerial BioPharma’s ADX-N05 asset sale to Jazz Pharmaceuticals. While Karen Adams life sciences experience has been primarily focused on early-stage, privately funded companies she was brought on as Assistant Controller at Millennium Pharmaceuticals, Inc. during its merger with COR Therapeutics – among the largest such mergers in the history of the biotech industry at that time. After Millennium Pharmaceuticals, Karen Adams went on to work with several early stage biotechnology ventures including Surface Logix, Inc., Compound Therapeutics, Inc., Galenea Corporation, BG Medicine, Inc., and Micell Technologies, Inc. Karen Adams contribution was concentrated on the creation of dynamic, integrated financial forecasting models as well as the implementation of core business structure. Karen Adams graduated from Boston College earning a BS in Management, majoring in Finance.
Follow Karen Adams:
About Arrivo BioVentures LLC, Emergo Therapeutics, KJA Associates, QuatroBio: Arrivo BioVentures is a pharmaceutical development company which focuses on identifying biologics and molecules to improve patient care.
David Cristman
Chief Financial Officer of ClearCare
Follow David Cristman:
About ClearCare, ClearCare: ClearCare is a web-based software solution that helps home care agencies efficiently focus on what’s important: providing better care.
Nancy Corrie
Consulting CFO of Tensility Venture Partners
Follow Nancy Corrie:
About Apex Venture Partners, Corazon Capital, High Alpha, Hyde Park Venture Partners, Network Ventures, Spiral Sun Ventures, Tensility Venture Partners: Tensility Venture partners with founders of early-stage enterprise startups in security, digital health, and novel, vertical-applications.
Daniel Schneiderman
Chief Financial Officer of First Wave BioPharma
Follow Daniel Schneiderman:
About First Wave BioPharma: First Wave BioPharma aims to become a leader in developing non-systemic, recombinant protein therapies.
Glenn S. Boehnlein
Chief Financial Officer & Vice President of Stryker
Follow Glenn S. Boehnlein:
About Stryker: Stryker is a medical technology company that offers products and services in orthopaedics.
Marty Ellen
CFO of Dr Pepper Snapple Group
Marty Ellen is chief financial officer for Dr Pepper Snapple Group, Inc. He is responsible for the company’s finance and IT organizations. Marty joined the company in April 2010 and brings to his role more than 25 years of broad experience serving as chief financial officer with companies in the manufacturing, distribution, franchising and services industries. Prior to his appointment at DPS, he served as senior vice president and chief financial officer of Snap-on Incorporated, a global innovator, manufacturer and marketer of tools, diagnostics, equipment, software and service solutions for professional users. His previous experience includes a role as senior vice president and chief financial officer at Whitman Corporation, which then owned Pepsi Cola General Bottlers, Inc. While at Whitman, Marty was instrumental in developing and executing strategy, including the realignment and expansion of Pepsi bottling territories in the U.S. and central Europe. He began his career as a senior audit manager with the international accounting firm, Price Waterhouse. Marty holds a bachelor’s degree in accounting from the University of Illinois, is a certified public accountant and earned a master’s degree in business administration from Northwestern University’s Kellogg Graduate School of Management, where he serves on the Alumni Advisory Board. Marty also serves on the Board of Directors of Eagle Materials Inc.
Follow Marty Ellen:
About Dr Pepper Snapple Group: Dr Pepper Snapple Group, Inc. (DPS) is an integrated brand owner, manufacturer and distributor of non-alcoholic beverages
Isaac Ro
Chief Financial Officer of Sema4
Isaac Ro has 20 years of financial leadership and experience, with a strong focus on the medical technology and life sciences space. As Chief Financial Officer (CFO) at Sema4, Isaac is responsible for leading all aspects of financial strategy, management, and planning. Prior to joining Sema4, Isaac served as CFO of Thrive Earlier Detection Corp., a company dedicated to incorporating earlier detection of cancer into routine medical care. In this capacity, he led the sale of Thrive to Exact Sciences Corp. (Nasdaq: EXAS) for $2.15 billion after rapidly scaling the company and raising $257 million in a Series B financing. Before Thrive, Isaac led the U.S. Medical Technology team at Goldman Sachs where he covered the Life Science Tools, Diagnostics, and Medical Technology sectors. He also held a similar role at SVB Leerink. His career as an equity analyst spanned 16 years, over 60 publicly traded companies, and numerous IPOs and equity financing transactions. Isaac holds a B.A. in History and was pre-med at Middlebury College.
Follow Isaac Ro:
About Sema4: Sema4 uses artificial intelligence and machine learning to analyze patient data to provide insights to transform the practice of medicine.
Ali Byrd
Chief Financial Officer of Olive
Ali is a builder and leader of high-performance finance and operations for early and growth-stage companies spanning clean tech, digital music, software, fintech, marketing, and more. As a serial startup Chief Financial Officer, he has executed financial modeling, transactions, and post-merger integrations. In 1997, Ali joined Microsoft, leading developer evangelism and competitive engagement for East Coast enterprise sales and consulting teams. He later oversaw product management and the launch of Microsoft’s SharePoint business, as well as strategic planning and growth for Microsoft’s $10B Office business. He also was responsible for M&A due diligence and post-merger management for Microsoft’s venture acquisitions. Ali subsequently joined the Global Technology Investment Banking group at Lehman Brothers, providing M&A and corporate finance advisory. He later joined the next-generation biofuels company Primafuel, a World Economic Forum Technology Pioneer, where he led fundraising and infrastructure projects. In 2011, he joined SecondMarket as Senior Vice President, facilitating $2B+ in secondary transactions for the world’s best venture-backed private companies. He then joined Movable Ink as CFO, producing record growth and profitability for the marketing personalization company. He also served as CFO of Olapic, a visual marketing leader that he helped sell to Monotype in 2016. Ali earned his BSE in Electrical Engineering from Duke and is now a regional board member for Duke New York. His MBA is from the Wharton School of Business, with a concentration on finance and entrepreneurship.
Follow Ali Byrd:
About Olive: Olive develops an artificial intelligence workforce for the health care industry.
David Morris
Executive Vice President & Chief Financial Officer of Guardian Pharmacy
CFO, Central Pharmacy Services, joining shortly after inception to build the central support and financial structure necessary to serve the dispersed, autonomous business units in a rapid growth entrepreneurial environment. Organizational units included accounting, information systems, human resources, M&A/business development, and administrative services. President, PBM Div., Complete Health. Established and operated Rx Management, a subsidiary PBM division of HMO Complete Health, which provided prescription drug management services to parent HMO’s/PPO’s and other Fortune 500 self-funded employer groups. C.P.A., Auditor, EY.
Follow David Morris:
About Guardian Pharmacy: Guardian Pharmacy is a pharmacy company provide outstanding client service to long-term care facilities.
Kim Witmer
Senior Vice President & Chief Financial Officer & Treasurer of Salk Institute for Biological Studies
Kim Witmer is Senior Vice President, Chief Financial Officer and Treasurer of the Salk Institute. She oversees all financial activities of the Salk, including financial reporting and treasury functions, research accounting, annual budgets, procurement, grants administration and endowment/investment management. Prior to joining the Salk, Witmer worked for the international accounting firm of Deloitte & Touche. Witmer also acts as past President of AIRI, the Association of Independent Research Institutes, as well as serving on AIRI’s Board of Directors and Government Affairs Committee. AIRI brings together nearly 100 independent, not-for-profit biomedical and behavioral research institutes whose mission is to enhance the ability of its members to improve human health and advance knowledge. Additionally, Witmer served as the Chief Financial Officer and Treasurer of the Sanford Consortium for Regenerative Medicine (SCRM), and currently holds a position on SCRM’s Administrative Council as the Salk representative. She is a Certified Public Accountant and holds a B.S. in business administration from San Diego State University.
Follow Kim Witmer:
About Salk Institute for Biological Studies: Salk Institute for Biological Studies conducts research on molecular biology and genetics, neurosciences, and plant biology.
Chris Power
Chief Financial Officer of Welltok
Chris is responsible for leading and guiding Welltok’s continued growth, driving margin expansion and profitability, and leading a world-class finance organization. Chris is a highly-accomplished CFO bringing over 25 years of financial, strategic and operational leadership to Welltok. He has an outstanding track record driving profitable growth at numerous private and public companies. Chris most recently served as CFO of Paycor, a leading human capital management SaaS company. He was also previously CFO of LifeLock, where he led the company’s IPO and helped quadruple its revenue. Additionally, Chris held senior leadership positions for other notable technology companies, including Salary.com, Monster Worldwide and Nortel Networks.
Follow Chris Power:
About Welltok: Welltok is a data-driven, enterprise SaaS company that delivers a healthcare consumer activation platform.
Wayne DeVeydt
Executive Vice President and Chief Financial Officer of Anthem
Wayne S. DeVeydt serves as executive vice president and chief financial officer for Anthem, Inc. Mr. DeVeydt joined Anthem in March 2005 as senior vice president and chief accounting officer, responsible for the company’s accounting and financial reporting, tax and financial systems. He assumed responsibility for investor relations and became chief of staff to the chairman and chief executive officer in 2006. Mr. DeVeydt became chief financial officer in May 2007 and is responsible for overseeing the financial operations associated with the company’s more than $74 billion in annual revenues. He is exceptionally skilled in planning, developing, supervising and implementing business strategies that achieve optimum productivity and cost efficiency. Mr. DeVeydt is often praised for his down-to-earth communications style that delivers key financial information in easy-to-understand terms. Mr. DeVeydt leads the following areas: treasury functions, such as capital planning, investments and cash management; investor relations; budgeting and forecasting; financial reporting; tax planning and compliance; accounting; and internal audit and compliance. Additionally, he oversees the actuarial functions including pricing, product development, valuation, health care management support, forecasting and other types of actuarial analysis. Prior to joining Anthem, Mr. DeVeydt was a partner with PricewaterhouseCoopers, LLP. Mr. DeVeydt was voted Best Managed Care CFO for 2012 by Institutional Investor and has been recognized by the global publication on numerous occasions. Mr. DeVeydt was also named Best Managed Care CFO in 2008 and 2011. He was recognized by the Indianapolis Business Journal as 2011 CFO of the Year in the Public Companies category. Mr. DeVeydt currently serves as a board member on a national level for the U.S. Chamber of Commerce, and was appointed to Boys & Girls Clubs of America’s esteemed Board of Governors in January 2015. BGCA’s board offers strategic leadership to the organization, guiding the work of more than 4,100 Clubs and affiliated youth centers on military installations worldwide. Each year, Clubs impact nearly 4 million kids and teens. A leader in youth development, BGCA’s vision calls for all Club members to graduate from high school with a plan for the future, demonstrating good character and citizenship, and leading a healthy lifestyle. Mr. DeVeydt is also an active leader in his community, serving as a board member of the Cancer Support Community, an international non-profit dedicated to providing support, education and hope to people affected with cancer. He previously served as a board member for the YMCA of Greater Indianapolis and The Children’s Museum of Indianapolis, the world’s largest children’s museum. Mr. DeVeydt received a Bachelor of Science in Accountancy from the University of Missouri in St. Louis.
Follow Wayne DeVeydt:
About Anthem: Anthem is a leading health benefits company dedicated to improving lives and communities, and making healthcare simpler.
Susan M. Kanaya
Senior Vice President, Finance, Chief Financial Officer and Secretary of ChemoCentryx
Ms. Susan M. Kanaya has served as our Senior Vice President, Finance, and Chief Financial Officer since January 2006, and Secretary since February 2006. Prior to joining us, Ms. Kanaya served as Senior Vice President, Finance, and Chief Financial Officer at Kosan Biosciences Inc., a biotechnology company, from 1999 to 2005. Prior to this, she served in financial management positions at SUGEN, Inc., a biotechnology company, from 1994 to 1999, most recently as Vice President, Finance, and Treasurer. Ms. Kanaya also served as Controller with high technology companies and as a public accountant with KPMG. Ms. Kanaya received her B.S. in business administration from the University of California, Berkeley.
Follow Susan M. Kanaya:
About ChemoCentryx: ChemoCentryx develops orally administered small molecule therapeutics that target chemokine receptors and related chemo-attractants.
Brian Jung
CFO of AiCure
Brian Jung is the CFO of AiCure.
Follow Brian Jung:
About AiCure: AiCure is an advanced data analytics company that uses artificial intelligence to understand how patients respond to treatments.
Phillip Donenberg
Senior Vice President, Chief Financial Officer of AveXis
Phillip brings more than 23 years of leadership expertise in finance, mergers and acquisitions (M&A) and operations focused in the pharmaceutical and healthcare industries. His background includes recent experience with a gene therapy company, AveXis, Inc., where he served as the Chief Financial Officer and Senior Vice President until June 15, 2018, following its acquisition by Novartis. Phillip has held leadership roles overseeing strategic transactions, financing management and accounting operations, controls and reporting processes for growing life sciences companies. Most recently, he was Chief Financial Officer and Senior Vice President of Depomed, Inc. Previously, Phillip was the Chief Financial Officer at RestorGenex Corporation from 2014 to 2016, when RestorGenex merged with Diffusion Pharmaceuticals, Inc. From 1998 to 2013, he served as the Chief Financial Officer at BioSante Pharmaceuticals, Inc. until the merger of the company with ANIP Pharmaceuticals, Inc. Phillip earned a bachelor’s degree in accountancy from the University of Illinois, and he is a Certified Public Accountant.
Follow Phillip Donenberg:
About AveXis, Jaguar Gene Therapy: AveXis is a Biotech company is focused on developing gene therapy for patients with rare and life-threatening neurological genetic diseases.
Mike Browder
Executive Vice President & CFO of RCCH HealthCare Partners
Mike Browder served as Executive Vice President and CFO for RegionalCare since 2011. Mike also led Essent Healthcare as CEO for four years. Mike previously served as Senior Vice President and Chief Financial Officer for TMC HealthCare, Tucson Arizona, for two years where he was responsible for the financial aspects of all TMC HealthCare companies, including the Tucson Medical Center. From 1993 to 1999, Mike served as Vice President of Operations Finance for Health Management Associates, Inc. Mike began his career in the Atlanta office of Ernst & Young where he audited and consulted with a broad array of healthcare-related companies. Mike currently serves on the Board of Directors of the Federation of American Hospitals. Mike is a member of the American Institute of Certified Public Accountants, the Tennessee Society of Certified Public Accountants, Financial Executives Institute and an advanced member of the Healthcare Financial Management Association. Mike earned a B.B.A in accounting from the University of Georgia’s J.M. Tull School of Accounting.
Follow Mike Browder:
About RCCH HealthCare Partners: RCCH HealthCare Partners provides healthcare services.
Stephen Mengert
CFO of eviCore healthcare
Stephen Mengert is the chief financial officer of [Medsolutions](https://www.crunchbase.com/organization/evicore-healthcare), a health technology company that offers proven, diversified medical benefit management solutions. He was previously the chief financial officer of Matria Healthcare. Before joining Matria Healthcare, he served as the chief financial officer of Tatum CFO Partners, Pediatric Services of America. He also served in numerous financial management positions, and currently also serves as director of Informed Medical Decisions and Adeptus Health. He is also a member of the Financial Executives Institute. Mengert holds a bachelor’s degree in finance and an MBA in finance from Georgia State University.
Follow Stephen Mengert:
About eviCore healthcare: eviCore healthcare offers a range of diversified medical benefit management solutions.
John Christopher Shea
CFO of Healthcare Services Group
Follow John Christopher Shea:
About Healthcare Services Group: Healthcare Services Group provides professional management of ancillary services to a wide range of clients.
Bob Dimond
Executive Vice President & Chief Financial Officer of Albertsons LLC
Bob Dimond has over 25 years of financial and senior executive management experience in the retail food and distribution industry. Prior to joining Albertson’s in February 2014 as Chief Financial Officer, he served as Chief Financial Officer and Treasurer at Nash Finch. He has also held the position of CFO for Wild Oats, the western region of Kroger Company, and Fred Meyer. Earlier in his career he was Vice President, Administration and Controller for Smith’s Food and Drug Centers. He earned his BS degree in accounting from the University of Utah and is a Certified Public Accountant.
Follow Bob Dimond:
About Albertsons LLC: Albertsons is one of the largest food and drug retailers in the United States, with both a strong local presence and national scale.
Richard Haydock
CFO of PulsePoint
Follow Richard Haydock:
About PulsePoint: PulsePoint is a technology company using data to accelerate healthcare marketing.
Richard Haydock
CFO of PulsePoint
Follow Richard Haydock:
About PulsePoint: PulsePoint is a technology company using data to accelerate healthcare marketing.
Paul Herendeen
Executive Vice President and Chief Financial Officer of Zoetis India Ltd
Paul Herendeen is executive vice president and chief financial officer (EVP and CFO) of Zoetis. In his role, Herendeen oversees the company’s Finance and Information Technology organizations and serves as part of the Zoetis Executive Team, reporting to CEO Juan Ramón Alaix. Herendeen brings more than 30 years of broad financial experience and leadership to his role at Zoetis, including 16 years as CFO of Warner Chilcott and MedPointe. From 2005 to 2013, Herendeen served as CFO at Warner Chilcott, a specialty pharmaceuticals company, which had a successful IPO in 2006, grew its revenue and profitability, and was acquired by Actavis in 2013. He joined Warner Chilcott after four years as EVP and CFO of MedPointe, a privately held health care company. He had been Warner Chilcott’s CFO from 1998 until 2000, joining the company after representing one of its lead investors on Warner Chilcott’s Board of Directors. Herendeen helped grow the company’s revenues and conduct its first successful IPO, and later helped complete the company’s acquisition by Galen PLC. From 1989 to 1998, Herendeen spent nine years as a principal investor at both Dominion Income Management and Cornerstone Partners, where he worked on investments as well as mergers and acquisitions for the firms and their portfolio companies. He also spent the early part of his career in banking and public accounting, having held various positions with the investment banking group of Oppenheimer & Company, the capital markets group of Continental Bank Corporation, and as a senior auditor with Arthur Andersen & Company. Herendeen earned a Master of Business Administration (MBA) from the University of Virginia’s Darden School of Business, and holds a bachelor’s degree in Business Administration from Boston College.
Follow Paul Herendeen:
About Bausch Health, Zoetis India Ltd: Zoetis provides healthcare services for animal.
Marc Nathan
Chief Financial Officer of Community Veterinary Partners
He’s the president of Calico Financial. He also served as chief financial officer of Community Veterinary Partner from 2009 through 2014. Marc is a director at Calico Real Estate and Community Veterinary Partners. He is also managing director at Calico Group. Before co-founding MDM, he most recently was a director of private equity at CMS Companies. At CMS, which he joined in 2002, Marc was a manager of the CMS Small-Cap Private Equity Fund, which made buyout investments in small companies. He has led investments into companies that focus on retail food service, building services, heath care services and others. Before joining CMS, Marc worked in the investment banking and capital markets divisions of National City Bank, CIT Merchant Banking, and First Union Securities. Marc has a masters degree in accounting from Drexel University and a bachelor’s degree from Penn State University. He lives outside Philadelphia with his wife, Marnie, and daughter, Jordanna. They have a portuguese water dog named Izzy.
Follow Marc Nathan:
About Community Veterinary Partners, Mdm Equity Partners: Community Veterinary Partners co-owns and manages hospitals with veterinarian owners to create a long-term and sustainable practice.
Bert Zimmerli
Senior VP, CFO of Intermountain Healthcare
Follow Bert Zimmerli:
About Intermountain Healthcare: Intermountain Healthcare is a nonprofit health system.
Robert Pietrucha
CFO of Guy Carpenter & Company
Robert Pietrucha is the Chief Financial Officer of Guy Carpenter and a member of the firm’s Board of Managers. Previously, Mr. Pietrucha served as the Finance Director of Marsh’s International Division. Before joining Marsh, Mr. Pietrucha worked with Johnson & Higgins, including assignments within the Controllership and Strategic Planning department, and also worked with Mercer’s corporate finance division. Prior to joining Marsh & McLennan Companies, Mr. Pietrucha worked as a Senior Auditor with Arthur Andersen & Co., where he earned his CPA. Mr. Pietrucha attended Ohio Wesleyan University, where he received a Bachelor of Arts degree in accounting.
Follow Robert Pietrucha:
About Guy Carpenter & Company: Guy Carpenter & Company, LLC operates as a reinsurance intermediary. The company offers accident and health, agriculture, alternative risk
Shalini Sharp
CFO of Ultragenyx Pharmaceutical
Shalini Sharp joined Ultragenyx in May 2012 as Chief Financial Officer and Senior Vice President, Finance. She is a member of the Senior Management Team and is responsible for leading the corporate finance function, including strategic financial planning, accounting, budgeting and forecasting, financial analysis, general risk analysis, and financing activities. Shalini Sharp is a member of the Board of Directors of Agenus Inc. (formerly Antigenics Inc.), a publicly traded biotechnology firm, where she served as Chief Financial Officer from 2006 to 2012. She joined Agenus in 2003 and held increasing roles of responsibility spanning strategic planning, corporate development, investor relations, corporate finance and business development. Prior to Agenus, Shalini Sharp held similar roles at Elan Pharmaceuticals from 1998 to 2003, including serving as chief of staff to the Chairman of the Board of Directors during that company’s restructing. With 16 years of industry experience, Shalini Sharp has spearheaded numerous financing and business development transactions that have been critical to the success of Agenus and Elan. Prior to Elan, Shalini Sharp was a management consultant at McKinsey & Company as well as an investment banker at Goldman Sachs, specializing in pharmaceuticals and medical devices.
Follow Shalini Sharp:
About Ultragenyx Pharmaceutical: Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
Ethan Einwohner
Chief Financial Officer of Specified Testing Labs
I Ethan Einwohner formed Specified Testing Labs, LLC, a roll-up of environmental testing laboratories, in August 2013. Under Specified, Ethan led the acquisitions of the testing lab assets of: International Hydronics Corporation (Oct 2013); New Jersey Analytical Labs (Nov, 2013), CNA Environmental (Dec 2013); and Smith Environmental Labs (Apr 2014). At Specified, Ethan manages all financial aspects of the firm and has responsibilities for its acquisition and integration activities. With his laboratory operations team, Ethan forms and executes company strategy .
Follow Ethan Einwohner:
About CNA Environmental, Recurrent Capital Bridge Fund, Specified Testing Labs: Specified Testing Laboratories, LLC is a holding company of testing laboratories and related operating companies. Formed in September .
Martin Jackson
Executive Vice President & Chief Financial Officer of Select Medical
Martin F. Jackson has served as Executive Vice President & Chief Financial Officer for Select Medical since May 1999. Mr. Jackson previously served as a Managing Director of the Health Care Investment Banking Group for CIBC Oppenheimer from January 1997 to May 1999. Prior to that time, he served as Senior Vice President, Health Care Finance with McDonald & Company Securities, Inc. from January 1994 to January 1997. Prior to 1994, Mr. Jackson held senior financial positions with Van Kampen Merritt, Touche Ross, Honeywell and L’Nard Associates. Mr. Jackson serves on the Board of The Vista School, as well as several venture-backed companies.
Follow Martin Jackson:
About Select Medical: Select Medical treats approximately 30,000 patients in a typical day.
Lucinda Baier
Chief Financial Officer of Brookdale Senior Living
Cindy Baier joined Brookdale as Chief Financial Officer in December 2015. She is a financial and operating leader with more than 25 years of broad, multi-industry experience in a variety of companies, including Fortune 100 public companies and private equity backed ventures. Cindy is a seasoned public CFO, with experience that includes retail and services companies, who started her career in a Big Five public accounting firm. She has a demonstrated ability to drive significant business improvement. Cindy is a collaborative Certified Public Accountant, experienced with strategic planning, M&A, capital markets, investor relations, accounting, financial planning and analysis, SEC reporting, tax, and treasury. Cindy is a graduate of Illinois State University, with Bachelor and Master of Science degrees in Accounting.
Follow Lucinda Baier:
About Brookdale Senior Living: Brookdale lifestyles create fulfilling experiences for each resident every day.
